前列腺多参数MRI结构化报告:PI-RADS与Likert量表
本文为评论文章,讨论前列腺多参数MRI(mpMRI)中两种广泛使用的结构化报告系统——PI-RADS v2.1与Likert量表。两者均表现出良好的诊断效能和高癌症检出率,但存在关键概念差异。作者强调需对这两种解读与报告系统进行持续临床验证。
要点
- PI-RADS v2.1与Likert量表均用于前列腺mpMRI结构化报告,诊断效能良好。
- 两系统存在关键概念差异,阅片时需明确所用系统并规范报告。
- 两种系统均需持续临床验证以优化应用。
局限性
- 为评论文章,未提供原始研究数据或系统评价。
- 未报告具体诊断效能数值及验证方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Multiparametric MRI (mpMRI) plays a critical role in the detection, staging and risk stratification of prostate cancer (PCa). There are two widely accepted structured reporting systems used for interpretation of mpMRI of the prostate - PI-RADS v2.1 and Likert. Both these systems demonstrate good diagnostic performance with high cancer detection rates however have key conceptual differences. In this commentary, the authors highlight the individual strengths and areas of potential improvement as well as emphasize the need for continued clinical validation for these interpreting and reporting systems.
引用
- Desai S, Costa DN. PI-RADS and Likert scales for structured reporting in multiparametric MR imaging of the prostate. Br J Radiol. 2021. PMID: 34586917. doi:10.1259/bjr.20210758
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。